NVIDIA
NVDA
Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
UTMD Utah Medical Products
- 61.130
- +0.110+0.18%
Close Dec 23 16:00 ET
- 61.130
- 0.0000.00%
Post 16:00 ET
207.33MMarket Cap14.28P/E (TTM)
61.900High60.390Low28.62KVolume61.240Open61.020Pre Close1.75MTurnover0.98%Turnover Ratio13.38P/E (Static)3.39MShares84.22652wk High1.67P/B178.95MFloat Cap60.39052wk Low1.20Dividend TTM2.93MShs Float125.723Historical High1.96%Div YieldTTM2.48%Amplitude2.812Historical Low60.979Avg Price1Lot Size
Utah Medical Products Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -24.70%3.86M | -43.78%2.76M | -23.70%5.28M | 5.36%22.28M | -6.13%5.33M | -8.37%5.12M | 1.68%4.91M | 37.04%6.92M | -0.26%21.15M | 13.90%5.68M |
| Net income from continuing operations | -9.45%3.56M | -17.79%3.45M | -6.12%3.96M | 0.98%16.64M | -5.91%4.29M | -8.06%3.94M | 2.34%4.2M | 19.24%4.21M | 11.39%16.47M | 10.24%4.56M |
| Depreciation and amortization | -58.54%740K | -61.05%693K | -61.28%683K | -10.08%6.37M | -40.64%1.04M | 2.29%1.79M | 0.17%1.78M | -2.49%1.76M | -2.77%7.08M | -1.18%1.75M |
| Deferred tax | 63.19%-53K | -26.77%-161K | -18,200.00%-183K | -72.41%-681K | -3,021.43%-409K | -17.07%-144K | 10.56%-127K | 99.31%-1K | -645.28%-395K | -85.42%14K |
| Change In working capital | 11.13%-447K | -32.74%-1.28M | -15.56%749K | 89.53%-233K | 148.46%345K | -45.38%-503K | 0.21%-962K | 534.80%887K | -121.27%-2.23M | 32.89%-712K |
| -Change in receivables | -110.11%-9K | -132.55%-83K | -111.96%-214K | 532.38%2.27M | -74.34%137K | 107.67%89K | -62.50%255K | 409.52%1.79M | 53.54%-525K | 262.80%534K |
| -Change in inventory | -79.06%67K | 205.59%170K | 125.00%271K | 71.53%-670K | 188.54%255K | 128.19%320K | -33.06%-161K | -33.99%-1.08M | -385.15%-2.35M | 11.11%-288K |
| -Change in prepaid assets | -43.75%9K | 700.00%132K | -448.00%-87K | 170.31%45K | 144.07%26K | -61.90%16K | -135.48%-22K | 122.94%25K | 20.99%-64K | -28.26%-59K |
| -Change in payables and accrued expense | 44.61%-514K | -44.68%-1.5M | 396.18%779K | -362.29%-1.88M | 91.88%-73K | -148.64%-928K | 34.76%-1.03M | -87.85%157K | 3.77%716K | -147.66%-899K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -24.70%3.86M | -43.78%2.76M | -23.70%5.28M | 5.36%22.28M | -6.13%5.33M | -8.37%5.12M | 1.68%4.91M | 37.04%6.92M | -0.26%21.15M | 13.90%5.68M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 52.15%-89K | 64.06%-115K | 111.63%5K | 21.88%-639K | -136.84%-90K | 42.06%-186K | -44.14%-320K | 81.86%-43K | -48.19%-818K | 84.98%-38K |
| Capital expenditure reported | 49.46%-94K | 65.63%-110K | 48.84%-22K | 21.88%-639K | ---90K | ---186K | -44.14%-320K | 81.86%-43K | ---818K | ---- |
| Net PPE purchase and sale | --0 | --0 | --27K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 52.15%-89K | 64.06%-115K | 111.63%5K | 21.88%-639K | -136.84%-90K | 42.06%-186K | -44.14%-320K | 81.86%-43K | -48.19%-818K | 84.98%-38K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -375.17%-4.92M | -611.88%-7.19M | -279.69%-3.98M | 24.05%-4.17M | -16.41%-1.07M | -0.29%-1.04M | 71.56%-1.01M | -5,621.05%-1.05M | 49.71%-5.48M | 88.60%-920K |
| Net common stock issuance | ---3.87M | ---6.4M | ---2.99M | --0 | --0 | --0 | --0 | --0 | ---2.5M | --0 |
| Cash dividends paid | 1.77%-1.05M | -1.03%-1.08M | -1.78%-1.09M | -35.38%-4.28M | -1.90%-1.07M | -1.81%-1.07M | -0.94%-1.07M | ---1.07M | 72.41%-3.16M | 87.41%-1.05M |
| Proceeds from stock option exercised by employees | --0 | 390.00%294K | 357.14%96K | -32.76%117K | --0 | 80.00%36K | 1,400.00%60K | 10.53%21K | -68.93%174K | -53.05%131K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -375.17%-4.92M | -611.88%-7.19M | -279.69%-3.98M | 24.05%-4.17M | -16.41%-1.07M | -0.29%-1.04M | 71.56%-1.01M | -5,621.05%-1.05M | 49.71%-5.48M | 88.60%-920K |
| Net cash flow | ||||||||||
| Beginning cash position | 5.44%89.22M | 15.94%93.81M | 23.74%92.87M | 23.09%75.05M | 26.90%88.21M | 27.78%84.62M | 22.83%80.91M | 23.09%75.05M | 18.19%60.97M | 8.07%69.51M |
| Current changes in cash | -129.51%-1.15M | -226.79%-4.54M | -77.71%1.3M | 17.73%17.48M | -11.67%4.17M | -7.93%3.9M | 238.34%3.58M | 20.61%5.82M | 52.32%14.85M | 241.55%4.72M |
| Effect of exchange rate changes | 223.87%384K | -137.10%-46K | -1,067.57%-358K | 144.20%339K | -40.42%488K | 67.33%-310K | 117.51%124K | -47.89%37K | -111.88%-767K | 7,545.45%819K |
| End cash Position | 0.28%88.45M | 5.44%89.22M | 15.94%93.81M | 23.74%92.87M | 23.74%92.87M | 26.90%88.21M | 27.78%84.62M | 22.83%80.91M | 23.09%75.05M | 23.09%75.05M |
| Free cash flow | -23.67%3.77M | -42.37%2.65M | -23.54%5.25M | 6.46%21.64M | -7.09%5.24M | -6.32%4.94M | -0.37%4.59M | 42.90%6.87M | -1.56%20.33M | 19.18%5.64M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.